Robert Alexander Ingram
CIK 1219890 · last filed 2023-03-02
Robert Alexander Ingram is a corporate insider who has filed 307 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing shows the insider was granted $20.0K of BCRX on Mar 2, 2023. Across all open-market trades the lifetime net is −$8.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.3M across reported positions. 39 SEC filings were submitted jointly with WACHOVIA CORP NEW.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 350
DURHAM, NC 27701
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 100,198 | $7.88 | $789.6K | $29.0K | 32 | 2023-03-02 |
| BDTX | Director | 42,854 | $1.69 | $72.4K | $152.3K | 12 | 2022-12-19 |
| Novan, Inc. (NOVN) Delisted | Director | 16,978 | $0.09 | $1.6K | $307.3K | 9 | 2020-07-30 |
| WOLFSPEED, INC. (CREE) Delisted | Director | 77,710 | $79.12 | $6.15M | -$84.8K | 47 | 2018-10-18 |
| REGN | Director | 6,667 | $807.67 | $5.38M | -$708.0K | 2 | 2015-05-27 |
| EW | Director | 192,372 | $90.56 | $17.42M | -$3.95M | 14 | 2015-05-19 |
| ALLERGAN INC (AGN) Delisted | Director | 19,382 | — | — | -$1.22M | 72 | 2012-10-31 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | $0 | 2 | 2011-12-06 |
| LOW | Director | 8,000 | $198.22 | $1.59M | -$388.9K | 24 | 2011-04-04 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 0 | — | — | $0 | 39 | 2010-09-30 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Director | 0 | — | — | -$2.44M | 9 | 2010-06-09 |
Recent Filings
307 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-02 | BCRX | Grant (A) | +2,259 | $20.0K | EDGAR |
| 2022-12-19 | BDTX | Grant (A) | +9,375 | $14.1K | EDGAR |
| 2022-12-02 | BCRX | Grant (A) | +1,497 | $20.0K | EDGAR |
| 2022-09-19 | BDTX | Grant (A) | +6,584 | $17.3K | EDGAR |
| 2022-09-02 | BCRX | Grant (A) | +1,438 | $20.0K | EDGAR |
| 2022-06-17 | BDTX | Grant (A) | +8,498 | $17.3K | EDGAR |
| 2022-06-13 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | BCRX | Grant (A) | +12,866 | $0 | EDGAR |
| 2022-06-02 | BCRX | Grant (A) | +2,078 | $19.3K | EDGAR |
| 2022-03-18 | BDTX | Grant (A) | +5,795 | $17.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.